share_log

JonesTrading Initiates Coverage On HCW Biologics With Buy Rating, Announces Price Target of $8

Benzinga Real-time News ·  Nov 8, 2022 04:56

JonesTrading analyst Soumit Roy initiates coverage on HCW Biologics (NASDAQ:HCWB) with a Buy rating and announces Price Target of $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment